BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 27813699)

  • 1. Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?
    Richter SS; Marchaim D
    Virulence; 2017 May; 8(4):417-426. PubMed ID: 27813699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active screening and interfacility communication of carbapenem-resistant Enterobacteriaceae (CRE) in a tertiary-care hospital.
    Shimasaki T; Segreti J; Tomich A; Kim J; Hayden MK; Lin MY;
    Infect Control Hosp Epidemiol; 2018 Sep; 39(9):1058-1062. PubMed ID: 30022738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of screening methods, rates and policies for the detection of carbapenemase-producing Enterobacteriaceae in English hospitals.
    Berry C; Davies K; Woodford N; Wilcox M; Chilton C
    J Hosp Infect; 2019 Feb; 101(2):158-162. PubMed ID: 30092291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating serial screening cultures to detect carbapenemase-producing Enterobacteriaceae following hospital admission.
    Mookerjee S; Dyakova E; Davies F; Bamford K; Brannigan ET; Holmes A; Otter JA
    J Hosp Infect; 2018 Sep; 100(1):15-20. PubMed ID: 29883616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem-resistant enterobacteriaceae screening: A core infection control measure for critical care unit in India?
    Ramanathan YV; Venkatasubramanian R; Nambi PS; Ramabathiran M; Venkataraman R; Thirunarayan MA; Samundeeswari P; Ramakrishnan N
    Indian J Med Microbiol; 2018; 36(4):572-576. PubMed ID: 30880709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cessation of screening for intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in a low-endemicity intensive care unit with universal contact precautions.
    Jalalzaï W; Boutrot M; Guinard J; Guigon A; Bret L; Poisson DM; Boulain T; Barbier F
    Clin Microbiol Infect; 2018 Apr; 24(4):429.e7-429.e12. PubMed ID: 28962997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission.
    Goodman KE; Simner PJ; Klein EY; Kazmi AQ; Gadala A; Toerper MF; Levin S; Tamma PD; Rock C; Cosgrove SE; Maragakis LL; Milstone AM;
    Infect Control Hosp Epidemiol; 2019 May; 40(5):541-550. PubMed ID: 30915928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae.
    Banerjee R; Humphries R
    Virulence; 2017 May; 8(4):427-439. PubMed ID: 27168451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of universal screening for carbapenemase-producing Enterobacteriaceae in hospital inpatients.
    Lapointe-Shaw L; Voruganti T; Kohler P; Thein HH; Sander B; McGeer A
    Eur J Clin Microbiol Infect Dis; 2017 Jun; 36(6):1047-1055. PubMed ID: 28078557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessing the need for active surveillance of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the neonatal intensive care population.
    Song X; Soghier L; Floyd TT; Harris TR; Short BL; DeBiasi RL
    Infect Control Hosp Epidemiol; 2018 Dec; 39(12):1436-1441. PubMed ID: 30345942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the Xpert
    Hoyos-Mallecot Y; Ouzani S; Dortet L; Fortineau N; Naas T
    Int J Antimicrob Agents; 2017 Jun; 49(6):774-777. PubMed ID: 28411078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How frequently are hospitalized patients colonized with carbapenem-resistant Enterobacteriaceae (CRE) already on contact precautions for other indications?
    Goodman KE; Simner PJ; Klein EY; Kazmi AQ; Gadala A; Rock C; Tamma PD; Cosgrove SE; Maragakis LL; Milstone AM;
    Infect Control Hosp Epidemiol; 2018 Dec; 39(12):1491-1493. PubMed ID: 30269700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
    Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
    Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of, and risk factors for, carriage of carbapenem-resistant Enterobacteriaceae among hospitalized patients in Japan.
    Yamamoto N; Asada R; Kawahara R; Hagiya H; Akeda Y; Shanmugakani RK; Yoshida H; Yukawa S; Yamamoto K; Takayama Y; Ohnishi H; Taniguchi T; Matsuoka T; Matsunami K; Nishi I; Kase T; Hamada S; Tomono K
    J Hosp Infect; 2017 Nov; 97(3):212-217. PubMed ID: 28736270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and predictors of health care-associated infections among patients colonized with carbapenem-resistant Enterobacteriaceae.
    Correa AAF; Fortaleza CMCB
    Am J Infect Control; 2019 Feb; 47(2):213-216. PubMed ID: 30279017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of meticillin-resistant Staphylococcus aureus and carbapenemase-producing Enterobacteriaceae in Danish emergency departments - evaluation of national screening guidelines.
    Skjøt-Arkil H; Mogensen CB; Lassen AT; Johansen IS; Chen M; Petersen P; Andersen KV; Ellermann-Eriksen S; Møller JM; Ludwig M; Fuglsang-Damgaard D; Nielsen FE; Petersen DB; Jensen US; Rosenvinge FS
    J Hosp Infect; 2020 Jan; 104(1):27-32. PubMed ID: 31494129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenem-resistant Enterobacteriaceae in patients admitted to the emergency department: prevalence, risk factors, and acquisition rate.
    Salomão MC; Guimarães T; Duailibi DF; Perondi MBM; Letaif LSH; Montal AC; Rossi F; Cury AP; Duarte AJS; Levin AS; Boszczowski I
    J Hosp Infect; 2017 Nov; 97(3):241-246. PubMed ID: 28826688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active surveillance for carbapenem-resistant Enterobacteriaceae, vancomycin-resistant enterococci and toxigenic Clostridium difficile among patients transferred from long-term care facilities in Korea.
    Hwang JH; Park JS; Lee E; Bae JY; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Park SW; Kim NJ; Oh M; Kim HB
    J Hosp Infect; 2018 Aug; 99(4):487-491. PubMed ID: 29476883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients.
    Schwartz-Neiderman A; Braun T; Fallach N; Schwartz D; Carmeli Y; Schechner V
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1219-25. PubMed ID: 27452597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowing More of the Iceberg: How Detecting a Greater Proportion of Carbapenem-Resistant Enterobacteriaceae Carriers Influences Transmission.
    Bartsch SM; Wong KF; Stokes-Cawley OJ; McKinnell JA; Cao C; Gussin GM; Mueller LE; Kim DS; Miller LG; Huang SS; Lee BY
    J Infect Dis; 2020 May; 221(11):1782-1794. PubMed ID: 31150539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.